BDSX

BIODESIX INC

• NASDAQ·2h ago

  Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now

• NASDAQ·2h ago

  GRAIL Partners With Epic to Broaden Galleri Test Access Across US

• Reuters·2d ago

  Biodesix to present AACR data on novel multi-omic MRD monitoring test pipeline

• Reuters·03/20 12:06

  Biodesix study validates Nodify CDT lung nodule test specificity at 91-97% in 1,100 patients

• Reuters·03/20 12:06

  BIODESIX ANNOUNCES THE LARGEST LUNG NODULE BIOMARKER CLINICAL VALIDATION STUDY EVER PUBLISHED SUPPORTING EARLIER LUNG CANCER DIAGNOSIS

• TipRanks·03/10 00:10

  Biodesix Earnings Call Signals Growth With Caveats

• TipRanks·03/02 13:15

  Biodesix: Strong Execution, Margin Expansion, and Path to Profitability Support Buy Rating and $20 Target

• NASDAQ·02/28 10:03

  William Blair Upgrades Biodesix (BDSX)

• Dow Jones·02/27 21:53

  Biodesix Raised to Outperform From Market Perform by William Blair

• Benzinga·02/27 21:43

  William Blair Upgrades Biodesix to Outperform

• TipRanks·02/27 20:55

  Biodesix: Strengthened Balance Sheet, Expanding Sales Force, and Modest Revenue Outperformance Support Buy Rating at Attractive 1x Sales Valuation

• TipRanks·02/27 17:50

  Analysts Are Bullish on These Healthcare Stocks: Quoin Pharmaceuticals (QNRX), Biodesix (BDSX)

• TipRanks·02/27 15:45

  Biodesix: Accelerating Growth, First Positive EBITDA, and Strengthening Risk‑Reward Support Buy Rating

• Reuters·02/27 14:20

  BIODESIX INC <BDSX.O>: WILLIAM BLAIR RAISES TO OUTPERFORM RATING

• TipRanks·02/27 14:15

  Lake Street Reaffirms Their Buy Rating on Biodesix (BDSX)